Prices are updated after-hours

EMMA Nasdaq

Emmaus Life Sciences, Inc.

EMMA | $0.1138 385.44% 300

(0.0% 1d) (32.7% 1m) (-65.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-91.48% volume)
Earnings Calendar:
Market Cap: $ 7,038,071
https://www.emmausmedical.com/
Sec Filling | Patents | 57 employees

(United States) emmaus life sciences, inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare and orphan disease. we are initially focusing our product development efforts in sickle cell disease, a genetic disorder. our lead product candidate is an oral pharmaceutical grade l-glutamine treatment that demonstrated positive clinical results in our completed phase 3 clinical trial for sickle cell anemia and sickle ß0-thalassemia.

t-cell

add to watch list Paper trade email alert is off

Press-releases

Emmaus Life Sciences Reports Delayed Filing of Annual Report
Published: 2024-04-15 (Crawled : 20:00) - prnewswire.com
EMMA | $0.1138 385.44% 300

Professional, Scientific, and T...

| Email alert Add to watchlist
report life sciences

Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico
Published: 2024-02-02 (Crawled : 15:00) - prnewswire.com
EMMA | $0.1138 385.44% 300

Professional, Scientific, and T...

| 7.31% | O: 22.64% H: 0.0% C: 0.0%
life authorization sciences

Emmaus Life Sciences Reports Q3 2023 Financial Results
Published: 2023-11-14 (Crawled : 14:30) - prnewswire.com
EMMA | $0.1138 385.44% 300

Professional, Scientific, and T...

| -5.21% | O: 0.0% H: 0.0% C: 0.0%
life sciences financial results

Emmaus Life Sciences Reports Management Changes
Published: 2023-08-23 (Crawled : 14:00) - biospace.com/
EMMA | $0.1138 385.44% 300

Professional, Scientific, and T...

| Email alert Add to watchlist
management life sciences

Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA
Published: 2023-05-31 (Crawled : 21:00) - biospace.com/
EMMA | $0.1138 385.44% 300

Professional, Scientific, and T...

| -57.08% | O: 13.21% H: 6.67% C: 6.67%
endari life authorization sciences

Emmaus Life Sciences Reports Q1 2023 Financial Results and Provides Business Update
Published: 2023-05-15 (Crawled : 16:00) - biospace.com/
EMMA | $0.1138 385.44% 300

Professional, Scientific, and T...

| -64.45% | O: 0.0% H: 0.0% C: 0.0%
business life update sciences financial results

Amarin Urges Shareholders to Vote “Against” Sarissa’s Harmful Proposals at Upcoming General Meeting – IT HAS NO PLAN, NO NEW IDEAS AND AN UNDERQUALIFIED SLATE
Published: 2023-02-17 (Crawled : 14:00) - globenewswire.com
EMMA | $0.1138 385.44% 300

Professional, Scientific, and T...

| -76.3% | O: -4.17% H: 0.0% C: -4.24%
IRWD | $7.59 -0.78% -0.79% 3.6M

Health Technology

| -32.6% | O: 1.5% H: 4.38% C: 2.86%
INVA | $14.69 1.45% 1.43% 640K

Health Technology

| 18.79% | O: 0.82% H: 1.55% C: 1.06%
AMRN | $0.8799 -4.06% -4.23% 1M

Health Technology

| -50.32% | O: 0.53% H: 0.0% C: -2.13%
ARMP | $2.65 6.0% -3.77% 31K

Health Technology

| 17.22% | O: -0.37% H: 5.69% C: 2.21%
meeting

Global Hemoglobinopathies Market Report 2022: Rising Cases in Under-Developed Countries Boosts Growth
Published: 2023-01-16 (Crawled : 14:00) - prnewswire.com
ALNY | News | $145.045 -0.19% -0.19% 400K

Health Technology

| Email alert Add to watchlist
GBT | $68.49 0.02% -0.02%

Health Technology

| Email alert Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| Email alert Add to watchlist
ABT | News | $105.27 -0.6% -0.15% 7.3M

Health Technology

| Email alert Add to watchlist
DHR | $236.36 -1.27% 0.0% 4.2M

Health Technology

| Email alert Add to watchlist
PFE A | $25.39 -0.12% -0.12% 36M

Health Technology

| Email alert Add to watchlist
EMMA | $0.1138 385.44% 300

Professional, Scientific, and T...

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| Email alert Add to watchlist
global report growth market

Dr. Niihara Meets with Local Indian Governor
Published: 2022-12-20 (Crawled : 15:20) - prnewswire.com
EMMA | $0.1138 385.44% 300

Professional, Scientific, and T...

| -65.53% | O: 3.03% H: 6.35% C: 6.35%

Dr. Niihara Feted by Indian Government in Recognition of the Development of Endari®
Published: 2022-12-19 (Crawled : 15:20) - prnewswire.com
EMMA | $0.1138 385.44% 300

Professional, Scientific, and T...

| -65.53% | O: 9.09% H: 0.0% C: -8.33%
endari

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001209191-23-057328	4	2023-12-05	2023-11-30	Buy	P	7417	395124
0001209191-23-057328	4	2023-12-05	2023-11-29	Buy	P	4325	335724
0001209191-23-057328	4	2023-12-05	2023-11-28	Buy	P	1470	299724
0001209191-23-057328	4	2023-12-05	2023-11-14	Buy	P	132	44200
0001209191-23-057328	4	2023-12-05	2023-08-31	Buy	P	900	43100
0001209191-23-057328	4	2023-12-05	2023-08-25	Buy	P	1365	37100
0001209191-23-033573	4	2023-06-02	2023-05-31	Buy	P	28700	30600
0001209191-23-033573	4	2023-06-02	2022-09-20	Buy	P	750	287724